top of page

Dernières nouvelles

Patient Experience

Patient Voice

22 nov. 2024

The dawn of a new era for Canadians living with cholangiocarcinoma

Read more
The dawn of a new era for Canadians living with cholangiocarcinoma
Featuring:

Jennifer Nielsen

Advocacy

The Newmarket Era, ON

21 nov. 2024

Newmarket woman’s battle over meds for rare cancer calls into question how province decides what drugs are covered under OHIP

Read more
Newmarket woman’s battle over meds for rare cancer calls into question how province decides what drugs are covered under OHIP
Featuring:

Heather Trombley

Advocacy, In memory

CTV Kitchener, ON

14 nov. 2024

Kitchener, Ont. woman with incurable cancer dies, fight continues to get provincial funding for expensive drug treatment

Read more
Kitchener, Ont. woman with incurable cancer dies, fight continues to get provincial funding for expensive drug treatment
Featuring:

Noor Ayesha

Patient experience

Cancer Interviews, YouTube

13 nov. 2024

Cynthia Mitchell Cholangiocarcinoma Warrior Winnipeg, Manitoba, Canada

Read more
Cynthia Mitchell Cholangiocarcinoma Warrior Winnipeg, Manitoba, Canada
Featuring:

Cynthia Mitchell

Advocacy

CTV Calgary, AB

6 nov. 2024

Promising treatment gives fresh hope to patients with rare, deadly cancer

Read more
Promising treatment gives fresh hope to patients with rare, deadly cancer
Featuring:

Jennifer Nielsen, Brenda Clayton

  • Instagram
  • Facebook
  • Youtube
  • Twitter
logoImage.png
leaf-cihr-colour-en_edited.png

Le Collectif Canadien pour le cholangiocarcinome (C3) est financé par une subvention d'équipe révolutionnaire de la Société Canadienne du cancer en partenariat avec les Instituts de recherche en santé du Canada. Les fonds de la subvention pour le C3 sont gérés par l'Institut de recherche de l'Hôpital d'Ottawa, qui sert d'institut principal pour toutes les opérations collaboratives.

© 2025 www.cholangio.ca. All rights reserved.

bottom of page